Used in pharmaceutical research as a potent and selective inhibitor of certain kinases involved in inflammatory and immune-mediated diseases. Shows promise in modulating signaling pathways related to autoimmune conditions and cancer due to its ability to target specific protein kinases with high affinity. Its structure supports blood-brain barrier penetration, making it a candidate for central nervous system-targeted therapies. Also employed in the development of targeted protein degraders (e.g., PROTACs) owing to its strong binding properties and favorable pharmacokinetic profile.